STRIDES PHARMA SCI revenue breakdown overview

STRIDES PHARMA SCI revenue for the last year amounted to 36.88 B INR, the most of which — 36.88 B INR — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 30.70 B INR. The greatest contribution to the revenue figure was made by North America — last year it brought STRIDES PHARMA SCI 19.26 B INR, and the year before that — 12.06 B INR.